More BS from Boston Scientific
When I wrote about the BS about BSX (Boston Scientific Corp.), I had not seen the numbers that were released later yesterday. Exactly as I had suspected, the company reported that Q1 profit fell by as much as 64%. Ouch! No wonder the company CEO wants investors to believe that they are thinking “long-term.”
Demand for two major categofies of products – heart stents and implantable defibrillators – is declining since their safety and effectiveness is already under a cloud.
I thought that only politicians lied but when you hear CEO’s do that, you feel disappointed.
Tags: bsx – boston scientific – defibrillators – heart stents
If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.



Comments
No comments yet.
Sorry, the comment form is closed at this time.